-
Pitavastatin Calcium
API’s Name Indication Specification US DMF EU DMF CEP Pitavastatin Calcium Hypercholesterolemia In-House -
Pregabalin
API’s Name Indication Specification US DMF EU DMF CEP Pregabalin Epilepsy/Neuralgia In-House/EP 22223 √ CEP2016-141 -
Obeticholic Acid
API’s Name Indication Specification US DMF EU DMF CEP Obeticholic Acid Biliary cholangitis In-House -
Niraparib 1038915-60-4
API’s Name Indication Innovator Patent Expiry Date(The U.S) Niraparib 1038915-60-4 Ovarian/Fallopian,tube/primary peritoneal cancer Tesaro Jan.8, 2028 -
Ledipasvir Actone /PVP
API’s Name Indication Specification US DMF EU DMF CEP Ledipasvir Actone /PVP HCV In-House √ -
LCZ696(Sacubitril + Valsartan)
API’s Name Indication Specification US DMF EU DMF CEP LCZ696(Sacubitril + Valsartan) Heart failure In-House √ -
Lenalidomide
API’s Name Indication Specification US DMF EU DMF CEP Lenalidomide Oncology drug In-House 31804 √ -
Hydrochlorothiazide
API’s Name Indication Specification US DMF EU DMF CEP Hydrochlorothiazide Diuretics USP/EP/CEP 16750 √ CEP 2006-011 -
Folic Acid
API’s Name Indication Specification US DMF EU DMF CEP Folic Acid Vitamin USP/EP -
Enalapril Maleate
API’s Name Indication Specification US DMF EU DMF CEP Enalapril Maleate Hypertension USP/EP -
Dabigatran Etexilate Mesylate
API’s Name Indication Specification US DMF EU DMF CEP Dabigatran Etexilate Mesylate Anticoagulant In-House
